I am sorry to interrupt the Minister again. We are talking about signals given to the outside world, in these discussions that are now taking place about the voluntary scheme. As the noble Lord, Lord Lansley, asked, rather elegantly, why do we have two schemes in the first place? There is something very odd about levelling up to a voluntary scheme’s level with a big increase and, at the same time, sitting down with the industry and saying how much we love it and that we want a new, agreed programme, when the industry is talking about figures which are nowhere near the figures in these two schemes. It seems almost politically inept.
Branded Health Service Medicines (Costs) (Amendment) Regulations 2023
Proceeding contribution from
Lord Warner
(Crossbench)
in the House of Lords on Thursday, 25 May 2023.
It occurred during Debates on delegated legislation on Branded Health Service Medicines (Costs) (Amendment) Regulations 2023.
Type
Proceeding contribution
Reference
830 c1031 
Session
2022-23
Chamber / Committee
House of Lords chamber
Subjects
Librarians' tools
Timestamp
2023-05-26 10:38:25 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000006
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000006
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2023-05-25/23052555000006